15Jan
BIVDA response to Parliament’s vote on the Brexit deal
Today the House of Commons voted down the EU withdrawal agreement and the framework for the future relationship.
Doris-Ann Williams, BIVDA’s Chief Executive, commented: “Today’s vote casts a shadow of uncertainty over the UK’s future relationship with the EU. The IVD industry remains anxious about access for patients to essential diagnostic tests if there is no transition period after 29 March. We therefore call for positive steps to be taken in these testing times and urge Government and policy makers to provide clarity and create sufficient space for our sector so that it is able to meet the significant challenge of ensuring the supply of essential diagnostics tests to patients through 2019.”
For a copy of BIVDA's position paper on Brexit, click here.
Related
A new report from the British In Vitro Diagnostics Association (BIVDA) has called for NHS England to...
Read More >
Doris-Ann Williams MBE, Chief Executive of the British In Vitro Diagnostics Association (BIVDA), rep...
Read More >
Twickenham, UK – 11th October, 2018 – Lab Innovations, the UK’s only trade show dedicated to the ...
Read More >
IVD Market Statistics Report 2017 highlights differences in total healthcare expenditure and wide va...
Read More >
Today the Secretary of State for Health and Social Care, Matt Hancock MP, has announced his vision f...
Read More >
Doris-Ann Williams, Chief Executive of BIVDA, comments on the announcement of the Withdrawal Agreeme...
Read More >